Cargando…
Is the Harm-to-Benefit Ratio a Key Criterion in Vaccine Approval?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289520/ https://www.ncbi.nlm.nih.gov/pubmed/35860726 http://dx.doi.org/10.3389/fmed.2022.879120 |
| _version_ | 1784748683990925312 |
|---|---|
| author | Mörl, Falk Günther, Michael Rockenfeller, Robert |
| author_facet | Mörl, Falk Günther, Michael Rockenfeller, Robert |
| author_sort | Mörl, Falk |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9289520 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92895202022-07-19 Is the Harm-to-Benefit Ratio a Key Criterion in Vaccine Approval? Mörl, Falk Günther, Michael Rockenfeller, Robert Front Med (Lausanne) Medicine Frontiers Media S.A. 2022-07-04 /pmc/articles/PMC9289520/ /pubmed/35860726 http://dx.doi.org/10.3389/fmed.2022.879120 Text en Copyright © 2022 Mörl, Günther and Rockenfeller. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Medicine Mörl, Falk Günther, Michael Rockenfeller, Robert Is the Harm-to-Benefit Ratio a Key Criterion in Vaccine Approval? |
| title | Is the Harm-to-Benefit Ratio a Key Criterion in Vaccine Approval? |
| title_full | Is the Harm-to-Benefit Ratio a Key Criterion in Vaccine Approval? |
| title_fullStr | Is the Harm-to-Benefit Ratio a Key Criterion in Vaccine Approval? |
| title_full_unstemmed | Is the Harm-to-Benefit Ratio a Key Criterion in Vaccine Approval? |
| title_short | Is the Harm-to-Benefit Ratio a Key Criterion in Vaccine Approval? |
| title_sort | is the harm-to-benefit ratio a key criterion in vaccine approval? |
| topic | Medicine |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289520/ https://www.ncbi.nlm.nih.gov/pubmed/35860726 http://dx.doi.org/10.3389/fmed.2022.879120 |
| work_keys_str_mv | AT morlfalk istheharmtobenefitratioakeycriterioninvaccineapproval AT gunthermichael istheharmtobenefitratioakeycriterioninvaccineapproval AT rockenfellerrobert istheharmtobenefitratioakeycriterioninvaccineapproval |